moved:
Motion No. 6
That Bill C-13, in Clause 3, be amended by replacing line 31 on page 2 with the following:
“with the applicable law governing consent and that conforms to the provisions of the Human Pluripotent Stem Cell Research Guidelines released by the Canadian Institutes of Health Research in March, 2002, as detailed in the Regulations.”
Motion No. 80
That Bill C-13, in Clause 40, be amended by replacing line 5 on page 21 with the following:
“proposed research and the Agency has, in accordance with the regulations, received approval from a research ethics board and a peer review.”
Motion No. 81
That Bill C-13, in Clause 40, be amended by adding after line 5 on page 21 the following:
“(2.1) No person may use an in vitro embryo that was in existence before the coming into force of this Act for the purpose of research unless it conforms to the criteria set out in the Human Pluripotent Stem Cell Research Guidelines released by the Canadian Institutes of Health Research in March, 2002, as specified in the Regulations.”
Motion No. 82
That Bill C-13, in Clause 40, be amended by adding after line 5 on page 21 the following:
“(2.1) A person who wishes to undertake research involving stem cells from in vitro embryos must provide the Agency with the reasons why embryonic stems cells are to be used instead of stem cells from other sources.”
Motion No. 83
That Bill C-13, in Clause 40, be amended by adding after line 8 on page 21 the following:
“(3.1) The Agency shall not issue a licence under subsection (1) for embryonic stem cell research if there are an insufficient number of in vitro embryos available for that research.”
Motion No. 85
That Bill C-13, in Clause 40, be amended by replacing line 14 on page 21 with the following:
“licensee or any other individual who is qualified to be a licensee under this”
Motion No. 86
That Bill C-13, in Clause 40, be amended by adding after line 21 on page 21 the following:
“(5.1) Every licence involving deriving stem cell lines from in vitro embryos must include, in the prescribed form, the obligation on the licensee to provide the Agency with samples of the resulting stem cell lines.”
Motion No. 88
That Bill C-13 be amended by adding after line 27 on page 21 the following new clause:
“40.1 The Agency shall establish, for in vitro fertilization procedures, limits regarding, but not limited to, the following:
(a) the amount of all drug dosages that may be administered;
(b) the number of
(i) ova that may be harvested,
(ii) ova that may be fertilized,
(iii) in vitro embryos that may be implanted at any one time, and
(iv) embryos that may be cryogenically stored for reproductive purposes; and
(c) the length of time that an embryo may be stored.”
Motion No. 89
That Bill C-13, in Clause 42, be amended by replacing line 31 on page 21 with the following:
“42. The Agency shall, in accordance with”
Motion No. 90
That Bill C-13, in Clause 42, be amended
(a) by replacing line 31 on page 21 with the following:
“42. (1) The Agency shall, in accordance with”
(b) by adding after line 38 on page 21 the following:
“(2) The amendment, renewal, suspension or revocation under subsection (1) or section 41 may be appealed.”